Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."

NCT07172724 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Malaria Vivax

Interventions

BIOLOGICAL: Vivaxin vaccine manufactured by CT Vacinas/Cristália Laboratory
OTHER: Placebo

Sponsor

Federal University of Minas Gerais

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]